Finnish medtech startup AIATELLA has raised €2 million to advance its AI-driven cardiovascular imaging technology. This funding, led by Nordic Science Investments along with various venture capitalists and angel investors, will support clinical trials and enhance ultrasound-based screening for carotid artery narrowing.
AIATELLA’s Automated Image Measurement (AIM) technology processes images from MRI, CT, and ultrasound, allowing rapid detection and quantification of vascular abnormalities. This automation significantly reduces the time specialists spend on image analysis, enabling more focus on patient care. The company is pursuing medical approvals in Europe and North America.
AIATELLA also aims to develop portable ultrasound screening for early cardiovascular disease detection, targeting mass screenings to catch issues before serious symptoms arise. Its technology addresses the pressing demands of healthcare systems by promoting earlier intervention and equitable care, while actively working to identify differences in cardiovascular disease manifestations across diverse demographics.
Source link
